Current Opinion and Practice on Peritoneal Carcinomatosis Management: The North African Perspective

Frontiers in Surgery

article

Mohammed Anass Majbar¹  Basma El Khannoussi²  Raouf Mohsine¹  Saber Boutayeb³  Amin Makni⁴  Mourad Abid⁵  Mouna Ayadi⁶  Feriel Ksantini⁶  Zakia Kordjani⁵  Yousri Ballah⁵  Jemila Bouka⁷  Amine Benkabbou¹  Martin Hubner⁸  Amine Souadka¹  Hajar Essangri¹ 

[1] Surgical Oncology Department, National Institute of Oncology, University Mohammed V;Pathology Department, National Institute of Oncology, University Mohammed V;Medical Oncology Department, National Institute of Oncology, University Mohammed V;Surgical Department A, Rabta Hospital;Surgical Oncology Department, Batna Cancer Institute;Medical Oncology Department, Salah-Azaiz Institute;Surgical Oncology Department, National Institute of Oncology;Department of Visceral Surgery, University Hospital Centre Hospitalier Universitaire Vaudois and University of Lausanne

关键词: peritoneal carcinomatosis;    LMIC;    surveys and questionnaires;    North Africa;    HIPEC;    PIPAC;   

DOI  :  10.3389/fsurg.2022.798523

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Background The status of peritoneal surface malignancy (PSM) management in North Africa is undetermined. The aim of this study was to assess and compare current practice and knowledge regarding PSM and examine satisfaction with available treatment options and need for alternative therapies in North Africa. Methods This is a qualitative study involving specialists participating in PSM management in North Africa. The survey analyzed demographic characteristics and current knowledge and opinions regarding PSM management in different institutions. We also looked at goals and priorities, satisfaction with treatment modalities and heated intraperitoneal chemotherapy (HIPEC) usefulness according to specialty, country, years of experience, and activity sector. Results One-hundred and three participants responded to the survey (response rate of 57%), including oncologists and surgeons. 59.2% of respondents had more than 10 years experience and 45.6% treated 20–50 PSM cases annually. Participants satisfaction with PSM treatment modalities was mild for gastric cancer (3/10 [IQR 2–3]) and moderate for colorectal (5/10 [IQR 3–5]), ovarian (5/10 [IQR 3–5]), and pseudomyxoma peritonei (5/10 [IQR 3–5]) type of malignancies. Good quality of life and symptom relief were rated as main priorities for treatment and the need for new treatment modalities was rated 9/10 [IQR 8–9]. The perceived usefulness of systemic chemotherapy in first intention was described as high by 42.7 and 39.8% of respondents for PSM of colorectal and gastric origins, while HIPEC was described as highly useful for ovarian (49.5%) and PMP (73.8) malignancies. Conclusions The management of PSM in the North African region has distinct differences in knowledge, treatments availability and priorities. Disparities are also noted according to specialty, country, years of expertise, and activity sector. The creation of referral structures and PSM networks could be a step forward to standardized PSM management in the region.

【 授权许可】

CC BY